Pfizer Rescues Mylan with Upjohn Merger
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 8 (Table of Contents)
Published: 2 Aug-2019
DOI: 10.3833/pdr.v2019.i8.2446 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a move to narrow the company focus on prescription medicines, Pfizer has agreed to merge its off-patents drug business, Upjohn, with Mylan in a Reverse Morris Trust transaction...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS